These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26391415)

  • 1. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
    Chamberlain MC
    Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26391415
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
    Norden AD; Ligon KL; Hammond SN; Muzikansky A; Reardon DA; Kaley TJ; Batchelor TT; Plotkin SR; Raizer JJ; Wong ET; Drappatz J; Lesser GJ; Haidar S; Beroukhim R; Lee EQ; Doherty L; Lafrankie D; Gaffey SC; Gerard M; Smith KH; McCluskey C; Phuphanich S; Wen PY
    Neurology; 2015 Jan; 84(3):280-6. PubMed ID: 25527270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment: Medical therapy for recurrent or progressive meningiomas remains elusive.
    Iwamoto FM
    Neurology; 2015 Jan; 84(3):285. PubMed ID: 25527267
    [No Abstract]   [Full Text] [Related]  

  • 4. Author response.
    Wen PY; Norden AD
    Neurology; 2015 Sep; 85(12):1090. PubMed ID: 26645061
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.
    Johnson DR; Kimmel DW; Burch PA; Cascino TL; Giannini C; Wu W; Buckner JC
    Neuro Oncol; 2011 May; 13(5):530-5. PubMed ID: 21558077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue.
    Chamberlain MC; Glantz MJ; Fadul CE
    Neurology; 2007 Sep; 69(10):969-73. PubMed ID: 17785665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy.
    Nicosia L; Bucpapaj R; Barresi V; Damante R; Napoli G; Ghimenton C; Giaj-Levra N; Cancedda M; Flaminio S; Figlia V; Alongi F
    Neurochirurgie; 2021 Apr; 67(2):193-197. PubMed ID: 33190809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy.
    Simó M; Argyriou AA; Macià M; Plans G; Majós C; Vidal N; Gil M; Bruna J
    Cancer Chemother Pharmacol; 2014 May; 73(5):919-23. PubMed ID: 24619496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful mifepristone treatment of recurrent, inoperable meningioma.
    Haak HR; de Keizer RJ; Hagenouw-Taal JC; van Seters AP; Vielvoye GJ; van Dulken H
    Lancet; 1990 Jul; 336(8707):124-5. PubMed ID: 1975312
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
    Tsutsui T; Miyashita K; Sabit H; Fukui I; Hayashi Y; Mizokami A; Ikeda H; Nagatani H; Nakada M
    World Neurosurg; 2016 Jul; 91():670.e1-6. PubMed ID: 27046016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy: What is its role in meningioma?
    Sherman WJ; Raizer JJ
    Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea for treatment of meningioma.
    Cusimano MD
    J Neurosurg; 1998 May; 88(5):938-9. PubMed ID: 9576275
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical treatment of recurrent meningiomas.
    Chamberlain MC; Barnholtz-Sloan JS
    Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response.
    Pellerino A; Soffietti R; Rudà R
    J Neurooncol; 2016 Mar; 127(1):201-3. PubMed ID: 26614515
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of high risk or recurrent meningiomas with hydroxyurea.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2002 Mar; 9(2):156-8. PubMed ID: 11922703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of unresectable skull base meningiomas with somatostatin analogs.
    Schulz C; Mathieu R; Kunz U; Mauer UM
    Neurosurg Focus; 2011 May; 30(5):E11. PubMed ID: 21529167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for rare brain tumors veers from traditional tack.
    McBride G
    J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
    [No Abstract]   [Full Text] [Related]  

  • 18. Sunitinib for atypical and anaplastic meningioma.
    Rahman A
    Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328951
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy.
    Molpus KL; Wu H; Fuller AF
    Gynecol Oncol; 1998 Feb; 68(2):206-9. PubMed ID: 9514798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.
    Chamberlain MC
    Curr Opin Oncol; 2012 Nov; 24(6):666-71. PubMed ID: 22759739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.